Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: dutton: we are raising our price target to $0.90 per share
That's it.  There should be a similar blurb in the 10q for this past quarter that will mention the deals since Dec 1.
Share
New Message
Please login to post a reply